These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24635318)

  • 1. Letter: coeliac disease and small intestinal bacterial overgrowth--is dysmotility the missing link?
    Mooney PD; Evans KE; Sanders DS
    Aliment Pharmacol Ther; 2014 Apr; 39(8):902-3. PubMed ID: 24635318
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth.
    Jacobs C; Coss Adame E; Attaluri A; Valestin J; Rao SS
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1103-11. PubMed ID: 23574267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth.
    Strid H; Simrén M; Stotzer PO; Ringström G; Abrahamsson H; Björnsson ES
    Digestion; 2003; 67(3):129-37. PubMed ID: 12853724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Bowel Bacterial Overgrowth Associated with Persistence of Abdominal Symptoms in Children Treated with a Proton Pump Inhibitor.
    Sieczkowska A; Landowski P; Zagozdzon P; Kaminska B; Lifschitz C
    J Pediatr; 2015 May; 166(5):1310-1312.e1. PubMed ID: 25681195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proton-pump inhibitor therapy and small bowel bacterial contamination].
    Hamvas J
    Orv Hetil; 2012 Aug; 153(33):1287-93. PubMed ID: 22890175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestinal bacterial overgrowth.
    Rana SV; Bhardwaj SB
    Scand J Gastroenterol; 2008; 43(9):1030-7. PubMed ID: 18609165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are bacteria in the small intestine pathogenic and in need of treatment?].
    Menge H
    Leber Magen Darm; 1986 Mar; 16(2):82-92. PubMed ID: 3713419
    [No Abstract]   [Full Text] [Related]  

  • 8. Proton pump inhibitors, irritable bowel syndrome, and small intestinal bacterial overgrowth: coincidence or Newton's third law revisited?
    Chey WD; Spiegel B
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):480-2. PubMed ID: 20304096
    [No Abstract]   [Full Text] [Related]  

  • 9. Small intestinal fungal overgrowth.
    Erdogan A; Rao SS
    Curr Gastroenterol Rep; 2015 Apr; 17(4):16. PubMed ID: 25786900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small intestinal bacterial overgrowth in the symptomatic elderly.
    Riordan SM; McIver CJ; Wakefield D; Bolin TD; Duncombe VM; Thomas MC
    Am J Gastroenterol; 1997 Jan; 92(1):47-51. PubMed ID: 8995936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of small intestinal bacterial overgrowth in Parkinson's disease.
    Fasano A; Bove F; Gabrielli M; Petracca M; Zocco MA; Ragazzoni E; Barbaro F; Piano C; Fortuna S; Tortora A; Di Giacopo R; Campanale M; Gigante G; Lauritano EC; Navarra P; Marconi S; Gasbarrini A; Bentivoglio AR
    Mov Disord; 2013 Aug; 28(9):1241-9. PubMed ID: 23712625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the effects of proton pump inhibitors on the small intestine?
    Fujimori S
    World J Gastroenterol; 2015 Jun; 21(22):6817-9. PubMed ID: 26078557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.
    Sieczkowska A; Landowski P; Zagozdzon P; Kaminska B; Lifschitz C
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1190-1191. PubMed ID: 28800034
    [No Abstract]   [Full Text] [Related]  

  • 14. Small Intestinal Bacterial Overgrowth: A Primary Care Review.
    Krajicek EJ; Hansel SL
    Mayo Clin Proc; 2016 Dec; 91(12):1828-1833. PubMed ID: 27916156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).
    Sallam H; McNearney TA; Chen JD
    Aliment Pharmacol Ther; 2006 Mar; 23(6):691-712. PubMed ID: 16556171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L; Foti M; Ruggia O; Chiecchio A
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):504-8. PubMed ID: 20060064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intestinal bacterial overgrowth syndromes].
    Fernández Ibáñez A; Fernández Orcajo P
    Rev Esp Enferm Apar Dig; 1986 Jun; 69(6):587-93. PubMed ID: 3738138
    [No Abstract]   [Full Text] [Related]  

  • 18. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS; Chen GH; Lien HC; Yeh HZ
    Hepatology; 1998 Nov; 28(5):1187-90. PubMed ID: 9794900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal motor disorders associated with cyclical bacterial overgrowth in a rat model of enteritis.
    Porras M; Martín MT; Soler M; Vergara P
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G58-64. PubMed ID: 14962848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients.
    Madrid AM; Brahm J; Buckel E; Silva G; Defilippi C
    Am J Gastroenterol; 1997 Jun; 92(6):1044-5. PubMed ID: 9177529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.